Boric Acid (99.9% Granular) - Peru CAS: 10043-35-3
Related Insights
UN Warning of an "Even Wider" Conflict: What It Could Mean for Global Shipping Regulation
A recent UN warning of an "even wider" conflict has renewed attention on international shipping safety and potential multilateral regulatory action. Chemical procurement and compliance teams should monitor developments that could influence maritime operations, logistics and global trade.
Japan's Agrochemical Pivot Toward India: Following the Solar Materials Playbook
As Japanese chemical makers redirect investment from China to India across sectors like solar materials, agrochemical suppliers are watching whether a similar shift plays out in crop protection. For procurement teams managing fungicide, herbicide and insecticide portfolios, understanding whether this geographic pivot extends to agricultural chemicals matters for supply chain planning and sourcing strategy.
Global Production Forecast Cut: What Atradius's 2026 Warning Means for Chemical Procurement
Atradius expects global chemical production to grow by only about 0.6% in 2026, with continued geopolitical conflict potentially resulting in a 1.7% contraction. Procurement teams should prepare for tighter supply conditions, changing pricing dynamics and increased sourcing risks.
Pharmaceutical Supply Chain: H1 2026 Closing Risk Assessment
The first half of 2026 exposed major vulnerabilities in pharmaceutical supply chains. API concentration, shipping disruptions, and logistics risks are reshaping procurement strategies for H2 2026 and beyond.
The Chemical Procurement Playbook for H2 2026: Ten Decisions Every Professional Must Make This Week
H2 2026 begins with a critical decision window for chemical procurement professionals. From India duty deadlines and Gulf supply recovery to freight renegotiation, fertilizer contracts, and regulatory compliance, these ten strategic decisions could define procurement performance for the rest of the year.
India Duty Waiver Expiry: Pharmaceutical Packaging Input Cost Reset in July 2026
India's temporary customs duty waiver on key pharmaceutical packaging polymers expires, reshaping procurement costs for medical packaging manufacturers. Here's what pharmaceutical companies should expect in Q3 2026.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.